Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-005483
Filing Date
2024-11-08
Accepted
2024-11-08 17:23:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHARLES SCHWAB INVESTMENT MANAGEMENT INC ebsa1_110724.htm SC 13G/A 25771
  Complete submission text file 0001085146-24-005483.txt   27401
Mailing Address 211 MAIN STREET SAN FRANCISCO CA 94105
Business Address 211 MAIN STREET SAN FRANCISCO CA 94105 415-627-7000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC (Filed by) CIK: 0000884546 (see all company filings)

EIN.: 943106735 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82602 | Film No.: 241441924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)